TY - JOUR
T1 - A case of a diabetic patient with alcoholic liver cirrhosis in which glucose intolerance has improved markedly after Hassab's operation for portal hypertension
AU - Takefuji, Seiko
AU - Nakajima, Shouko
AU - Shibata, Miyuki
AU - Itoh, Mariko
AU - Matsunaga, Masaaki
AU - Kusada, Noriko
AU - Kunoh, Takao
AU - Nomura, Yoshio
PY - 2015
Y1 - 2015
N2 - The patient was a 60-year-old Japanese man with chronic alcoholism who presented with lower limb edema, abdominal distension and hyperglycemia(plasma glucose, 501 mg/dl;HbA1c, 9.2 %). A diagnosis of diabetes mellitus with liver cirrhosis was made and insulin therapy (48-64 IU/day) was started in 2010. For half a year the patient was under good diabetic control, however, his condition deteriorated (FPG; 408 mg/dl and HbA1c; 11.5 %). He was admitted with portal hypertension and Hassabs' surgery was performed in 2011. Following surgery, he made a recovery from portal hypertension and an improvement was observed in his diabetic-control. His glucose intolerance improved and insulin therapy was discontinued. He was discharged under good diabetic control (HbA1c; 5.5 %) with glimepiride treatment (0.5 mg/day). The glimepiride treatment was eventually ceased. We hope this case report will help some readers treat patients with portal hypertension and insulin-resistant diabetes mellitus more effectively.
AB - The patient was a 60-year-old Japanese man with chronic alcoholism who presented with lower limb edema, abdominal distension and hyperglycemia(plasma glucose, 501 mg/dl;HbA1c, 9.2 %). A diagnosis of diabetes mellitus with liver cirrhosis was made and insulin therapy (48-64 IU/day) was started in 2010. For half a year the patient was under good diabetic control, however, his condition deteriorated (FPG; 408 mg/dl and HbA1c; 11.5 %). He was admitted with portal hypertension and Hassabs' surgery was performed in 2011. Following surgery, he made a recovery from portal hypertension and an improvement was observed in his diabetic-control. His glucose intolerance improved and insulin therapy was discontinued. He was discharged under good diabetic control (HbA1c; 5.5 %) with glimepiride treatment (0.5 mg/day). The glimepiride treatment was eventually ceased. We hope this case report will help some readers treat patients with portal hypertension and insulin-resistant diabetes mellitus more effectively.
UR - http://www.scopus.com/inward/record.url?scp=84938889320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938889320&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84938889320
SN - 0021-437X
VL - 58
SP - 458
EP - 464
JO - Journal of the Japan Diabetes Society
JF - Journal of the Japan Diabetes Society
IS - 7
ER -